2nd Sino-EU Permed Science & Technology Webinar 'Perspectives in Personalised Medicine: Cancer treatment & diagnostics'

Sino-EU PerMed is a project funded by the European Commission with the purpose to foster international coordination of research and innovation, funding and policies within the field of personalised medicine. The project is a member of the family of projects under the umbrella of the International Consortium of Personalised Medicine (ICPerMed) which attempts to align and promote efforts in all areas of personalised medicine.

The Sino-EU PerMed project undertakes several activities to promote interactions between China and EU within the area of personalised medicine. A key part of the project is the exchange of expertise and PM knowledge via science and technology webinars, thereby promoting cooperation and networking activities.

The second webinar will focus on personalised treatment and diagnostics in cancer. Research on genetic links in cancer diseases and diagnoses triggered the start of personalised medicine more than 10 years ago. The area has developed significantly in recent years, and we are starting to see the first national cancer plans being implemented into health care. At this webinar examples from both China and Europe will be presented, demonstrating the state of the art of the field today.

For more information on the event and speakers please visit the Sino-EU PerMed website.

The final agenda will be published soon.

Link to online registration

Sino-EU PerMed has been granted funding through the EU Framework Programme for Research and Innovation ‘Horizon 2020’ under grant agreement no 874556..

Date and Time

13 December 2022 | online
8 a.m. to 12 noon CET, 3 p.m. to 7 p.m. CST